Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Apixaban in Subjects With End-stage Renal Disease Treated With Peritoneal Dialysis: the ApiDP Study

NCT04006093 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT04006093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04006093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Apixaban in Subjects With End-stage Renal Disease Treated With Peritoneal Dialysis: the ApiDP Study
Lead sponsor
University Hospital, Caen
Phase
Phase 1
Overall status
Completed
Start date
December 8, 2019
Completion date
December 10, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal insufficiency, peritoneal dialysis